Efficacy of antiplatelets in deep venous thrombosis

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

From the President: For 25 years, accreditation has paved the way

For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.

Pharmacy Board’s measured step on prescribing

The Pharmacy Board of Australia has recognised that pharmacists should be able to prescribe under two monitored models of prescribing, in a move welcomed...

Caring for our elders

This Royal Commission is an opportunity to improve how we care for our elderly, and release the chains holding pharmacists back from preventing inappropriate...

Systemic corticosteroids for dyspnoea

The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer. Dyspnoea affects almost 70% of advanced cancer patients at the...

Rural healthcare advocate honoured

NSW pharmacist Anna Barwick MPS was awarded the Medal of the Order of Australia (OAM) in the 2025 Australia Day Honours.